FEDERICO
PULIDO ORTEGA
Profesor asociado de Ciencias de la Salud
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (7)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians
The Lancet HIV, Vol. 11, Núm. 5, pp. e333-e340
2023
-
Deep Sequencing on Proviral DNA: More Questions than Answers
Journal of acquired immune deficiency syndromes (1999)
2022
-
48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort
PLoS ONE, Vol. 17, Núm. 11 November
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance
Open Forum Infectious Diseases, Vol. 9, Núm. 11
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836